SC 13G/A: Silence Therapeutics plc

AI Summary

SC 13G/A filing by Silence Therapeutics plc.

Risk Assessment

Risk Level: low

FAQ

Filing Documents

• d780589dsc13ga.htm (SC 13G/A) — 172KB
• d780589dex991.htm (EX-99.1) — 12KB
• 0001193125-24-193058.txt ( ) — 186KB

From the Filing

SC 13G/A 1 d780589dsc13ga.htm SC 13G/A SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934* (Amendment No. 2) Silence Therapeutics plc (Name of Issuer) Ordinary Shares, nominal value £0.05 per share (Title of Class of Securities) 82686Q101** (CUSIP Number) July 25, 2024 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. ** This CUSIP number applies to the Issuers American Depositary Shares, each representing three ordinary shares of the Issuer. The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 82686Q101 1 NAMES OF REPORTING PERSONS Invus Public Equities, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Bermuda NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 8,338,857* 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 8,338,857* 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,338,857* 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) PN * Invus Public Equities, L.P. holds an aggregate of 2,779,619 American Depositary Shares (ADSs), each of which ADS represents three ordinary shares, nominal value £0.05 per share, totaling 8,338,857 ordinary shares of the Issuer. 2 CUSIP No. 82686Q101 1 NAMES OF REPORTING PERSONS Invus Public Equities Advisors, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 8,338,857* 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 8,338,857* 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,338,857* 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO * Invus Public Equities, L.P. holds an aggregate of 2,779,619 American Depositary Shares (ADSs), each of which ADS represents three ordinary shares, nominal value £0.05 per share, totaling 8,338,857 ordinary shares of the Issuer. 3 CUSIP No. 82686Q101 1 NAMES OF REPORTING PERSONS Invus Global Management, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 8,338,857* 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 8,338,857* 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,338,857* 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO * Invus Public Equities, L.P. holds an aggregate of 2,779,619 American Depositary Shares (ADSs), each of which ADS represents three ordinary shares, nominal value £0.05 per share, totaling 8,338,857 ordinary shares of the Issuer. 4 CUSIP No. 82686Q101 1 NAMES OF REPORTING PERSONS Siren, L.L.C. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER 8,338,857* 6 SHARED VOTING POWER 0 7 SOLE DISPOSITIVE POWER 8,338,857* 8 SHARED DISPOSITIVE POWER 0 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 8,338,857* 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.0% 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) OO * Invus Public Equities, L.P. holds an aggregate of 2,779,619 American Depositary Shares (ADSs), each of which ADS represen

View Full Filing

View this SC 13G/A filing on SEC EDGAR